VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for Cytokinetics Inc Common Stock (CYTK)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Cytokinetics Inc Common Stock
Symbol: CYTK
Shares outstanding: 118,095,352 shares
Disclosed Ownership: 11,915,821 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 08 Jan 2025, 11:29:36 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10%	11,915,821	0	87,298	Ashley Grim	Head of Global Fund Administration